Evidence map›Paper›PMID 31534883›Full record

ArticleAsian journal of organic chemistry2019

Recent Developments in Stereoselective Chemical Glycosylation.

Jesse Ling, Clay S Bennett

Open access · greenAbstract read
In one paragraph

Article in Asian journal of organic chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Stereoselective Approaches to β-Linked 2-Deoxy Sugars.Molecules (Basel, Switzerland) · 2025
    Review
  7. Isothiourea - catalyzed α-selective glycosylations.Chemical communications (Cambridge, England) · 2025
    Article
  8. Article
  9. Article
  10. ZnIMolecules (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Directed SJournal of the American Chemical Society · 2023
    Article
  15. AuClOrganic letters · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Recent Advances in Stereoselective ChemicalFrontiers in molecular biosciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jesse LingDepartment of Chemistry, Tufts University, 62 Talbot Ave., Medford, MA 02155, USA.
Clay S BennettDepartment of Chemistry, Tufts University, 62 Talbot Ave., Medford, MA 02155, USA.
Tufts University · US

Funding

Reagent Control for Stereoselective Glycosylation ReactionsU01GM120414 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI BENNETT, CLAY SAMUEL · 2016 to 2019
$1.5M
Synthetic Studies on the Antibiotic Saccharomicin B.R01GM115779 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI BENNETT, CLAY SAMUEL · 2015 to 2018
$1.4M
NIGMS NIH HHS R01 GM115779NIGMS NIH HHS U01 GM120414
6 · The paper itself

Abstract

Because of their pivotal biological functions, attention to sugars and glycobiology has grown rapidly in recent decades, leading to increased demand for homogeneous oligosaccharides. The stereoselective preparation of oligosaccharides by chemical means remains challenging and continues to be a vivid research area for organic chemists. In the past decade, new approaches and reinvestigated traditional methods have transformed the field. These developments include novel catalyses, various types of glycosylation modulators and the use of photochemical energy to facilitate glycosylation. This Minireview presents a brief overview of the latest trends in chemical glycosylation, with emphasis on the stereoselective synthetic protocols developed in the past decade.

Indexed as

carbohydratesdiastereoselectivityglycosidesglycosylationoligosaccharides

Identifiers

PMID31534883
PMCPMC6750748
OpenAlexW2942621659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.